Instrument overview

6618JD Health International

StockHKEXChinaHealth careEU retail: available

−1.8% today · −41.4% over a year

No score: too little data.

No dividend.

JD Health International (6618) belongs to the Health care sector and is listed on HKEX; country: China. Over the past 12 months the price changed by −41.4%, with an annualised volatility of 41% and a largest fall of 54%.

Not scored: not enough data for a fair comparison.

Factor scores

Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 20% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 30% of peers

Percentiles within the peer group (100 = the best of its peers); dividend safety in points.

Main drivers

  • 12-month trend (ex last month)weighs on the score · better than 18% of peers
  • Betaweighs on the score · better than 21% of peers
  • Risk-adjusted 12-month trendweighs on the score · better than 16% of peers

Red flags and notes

No red flagsNone of our published warning rules is triggered right now.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Dividends

Dividend yield
0.00%
Years of dividend growth
0

Returns and risk

1 day
−1.8%
1 month
+2.5%
1 year
−41.4%
Volatility, 1 yr
41.3%
Max drawdown, 1 yr
−54.1%
Beta
1.12

Returns are price changes from end-of-day prices, without dividends.

Similar companies

Same sector, closest in price swings over the past year.

241Alibaba Health Information Technology—/108.1%−50.1%
1177Sino Biopharmaceutical—/102.5%−29.3%
BAYNBayer AG—/100.2%68.2%
3692Hansoh Pharmaceutical—/101.5%−5.7%
2359WuXi AppTec—/101.3%71.8%
ALKSAlkermes plc4/100.0%46.0%
4519Chugai Pharmaceutical Co., Ltd.—/103.2%−0.3%
GMABGenmab A/S—/100.0%96.7%

News and filings

No recent news or filings in our sources.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

No published ratings in the last 12 months.